Published in J Clin Immunol on June 05, 2012
Autoimmunity and inflammation in X-linked agammaglobulinemia. J Clin Immunol (2014) 1.01
Toll-like receptor signaling in primary immune deficiencies. Ann N Y Acad Sci (2015) 0.79
The tyrosine kinase Btk regulates the macrophage response to Listeria monocytogenes infection. PLoS One (2013) 0.79
The Tec Kinase-Regulated Phosphoproteome Reveals a Mechanism for the Regulation of Inhibitory Signals in Murine Macrophages. J Immunol (2015) 0.78
The role of Bruton's tyrosine kinase in autoimmunity and implications for therapy. Expert Rev Clin Immunol (2016) 0.77
The effects of Bruton tyrosine kinase inhibition on chemotaxis and superoxide generation in human neutrophils. J Clin Immunol (2014) 0.77
BTK mutations selectively regulate BTK expression and upregulate monocyte XBP1 mRNA in XLA patients. Immun Inflamm Dis (2015) 0.75
How will Bruton's tyrosine kinase inhibitors affect rheumatoid arthritis? Arthritis Rheumatol (2016) 0.75
Macrophage-activating lipopeptide-2 requires Mal and PI3K for efficient induction of heme oxygenase-1. PLoS One (2014) 0.75
Toll-like receptor 9 regulates melanogenesis through NF-κB activation. Exp Biol Med (Maywood) (2016) 0.75
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol (2010) 24.08
Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation. Nat Immunol (2006) 3.94
X-linked agammaglobulinemia: report on a United States registry of 201 patients. Medicine (Baltimore) (2006) 2.66
Bruton's tyrosine kinase is a Toll/interleukin-1 receptor domain-binding protein that participates in nuclear factor kappaB activation by Toll-like receptor 4. J Biol Chem (2003) 1.91
MyD88 adapter-like (Mal) is phosphorylated by Bruton's tyrosine kinase during TLR2 and TLR4 signal transduction. J Biol Chem (2006) 1.77
BTKbase: the mutation database for X-linked agammaglobulinemia. Hum Mutat (2006) 1.55
B cells in patients with X-linked agammaglobulinemia. J Immunol (1985) 1.48
Bruton's tyrosine kinase is required for TLR2 and TLR4-induced TNF, but not IL-6, production. J Immunol (2006) 1.43
Bruton's tyrosine kinase is required for lipopolysaccharide-induced tumor necrosis factor alpha production. J Exp Med (2003) 1.43
Signaling by Toll-like receptors 8 and 9 requires Bruton's tyrosine kinase. J Biol Chem (2007) 1.32
Genotype/phenotype correlations in X-linked agammaglobulinemia. Clin Immunol (2005) 1.20
Anti-inflammatory role for intracellular dimeric immunoglobulin a by neutralization of lipopolysaccharide in epithelial cells. Immunity (2003) 1.15
Bruton's tyrosine kinase is not essential for LPS-induced activation of human monocytes. J Allergy Clin Immunol (2006) 1.10
A genotype-phenotype correlation study in a group of 54 patients with X-linked agammaglobulinemia. J Allergy Clin Immunol (2005) 1.06
Bruton's tyrosine kinase is required for TLR-induced IL-10 production. J Immunol (2006) 1.04
Toll-like receptor signaling is impaired in dendritic cells from patients with X-linked agammaglobulinemia. Clin Immunol (2008) 1.02
Bruton's tyrosine kinase separately regulates NFkappaB p65RelA activation and cytokine interleukin (IL)-10/IL-12 production in TLR9-stimulated B Cells. J Biol Chem (2008) 1.02
Impaired Toll-like receptor 8-mediated IL-6 and TNF-alpha production in antigen-presenting cells from patients with X-linked agammaglobulinemia. Blood (2006) 1.00
Mal-function of TLRs by SOCS. Nat Immunol (2006) 0.99
Agammaglobulinemia with polyarthritis and subcutaneous nodules. Am J Med (1970) 0.94
[Autoimmune disease in primary antibody deficiencies]. Allergol Immunopathol (Madr) (2005) 0.90
Monozygous twins with a microdeletion syndrome involving BTK, DDP1, and two other genes; evidence of intact dendritic cell development and TLR responses. Eur J Pediatr (2007) 0.89
Defective Toll-like receptor 9-mediated cytokine production in B cells from Bruton's tyrosine kinase-deficient mice. Immunology (2007) 0.89
Bruton's tyrosine kinase is dispensable for the Toll-like receptor-mediated activation of mast cells. Cell Signal (2008) 0.88
Effect of multiple activation stimuli on the generation of Th1-polarizing dendritic cells. Hum Immunol (2010) 0.84
Toll-like receptor 4-, 7-, and 8-activated myeloid cells from patients with X-linked agammaglobulinemia produce enhanced inflammatory cytokines. J Allergy Clin Immunol (2011) 0.83
Characterization of Bruton's tyrosine kinase mutations in Mexican patients with X-linked agammaglobulinemia. Mol Immunol (2007) 0.79
Neutrophil extracellular traps are induced by Mycobacterium tuberculosis. Tuberculosis (Edinb) (2008) 1.60
CD38 is expressed selectively during the activation of a subset of mature T cells with reduced proliferation but improved potential to produce cytokines. J Leukoc Biol (2004) 1.24
First report of the Hyper-IgM syndrome Registry of the Latin American Society for Immunodeficiencies: novel mutations, unique infections, and outcomes. J Clin Immunol (2014) 1.18
IL-12Rβ1 deficiency: mutation update and description of the IL12RB1 variation database. Hum Mutat (2013) 1.15
Primary immunodeficiency diseases in Latin America: the second report of the LAGID registry. J Clin Immunol (2006) 1.08
In situ analysis of lung antigen-presenting cells during murine pulmonary infection with virulent Mycobacterium tuberculosis. Int J Exp Pathol (2004) 1.05
Mycobacterium tuberculosis lipids regulate cytokines, TLR-2/4 and MHC class II expression in human macrophages. Tuberculosis (Edinb) (2008) 1.00
CD38 induces apoptosis of a murine pro-B leukemic cell line by a tyrosine kinase-dependent but ADP-ribosyl cyclase- and NAD glycohydrolase-independent mechanism. Int Immunol (2006) 0.97
Myosin 1c participates in B cell cytoskeleton rearrangements, is recruited to the immunologic synapse, and contributes to antigen presentation. J Immunol (2011) 0.93
Expression of functional interleukin-12 from mouse in transgenic tomato plants. Transgenic Res (2005) 0.92
Activation of the innate immune response against DENV in normal non-transformed human fibroblasts. PLoS Negl Trop Dis (2011) 0.92
Translating innate response into long-lasting antibody response by the intrinsic antigen-adjuvant properties of papaya mosaic virus. Immunology (2007) 0.90
A Salmonella typhi OmpC fusion protein expressing the CD154 Trp140-Ser149 amino acid strand binds CD40 and activates a lymphoma B-cell line. Immunology (2003) 0.88
CD38 induces differentiation of immature transitional 2 B lymphocytes in the spleen. Blood (2008) 0.87
CD38 signaling regulates B lymphocyte activation via a phospholipase C (PLC)-gamma 2-independent, protein kinase C, phosphatidylcholine-PLC, and phospholipase D-dependent signaling cascade. J Immunol (2005) 0.87
Indications, usage, and dosage of the transfer factor. Rev Alerg Mex (2008) 0.86
Bruton's tyrosine kinase--an integral protein of B cell development that also has an essential role in the innate immune system. J Leukoc Biol (2013) 0.86
CD16+ human monocyte-derived dendritic cells matured with different and unrelated stimuli promote similar allogeneic Th2 responses: regulation by pro- and anti-inflammatory cytokines. Int Immunol (2004) 0.86
CD38 cross-linking enhances TLR-induced B cell proliferation but decreases IgM plasma cell differentiation. Eur J Immunol (2007) 0.86
The myosin family: unconventional roles of actin-dependent molecular motors in immune cells. J Leukoc Biol (2011) 0.85
Antigen-specific activation and proliferation of CD4+ and CD8+ T lymphocytes from brucellosis patients. Trans R Soc Trop Med Hyg (2002) 0.85
Treatment of Kimura disease with intravenous immunoglobulin. Pediatrics (2011) 0.85
Evaluation of the cell growth of mycobacteria using Mycobacterium smegmatis mc2 155 as a representative species. J Microbiol (2012) 0.85
CD38 is expressed as noncovalently associated homodimers on the surface of murine B lymphocytes. Eur J Biochem (2004) 0.84
CD38 through the life of a murine B lymphocyte. IUBMB Life (2011) 0.84
Antimycobacterial activity of Juglans regia, Juglans mollis, Carya illinoensis and Bocconia frutescens. Phytother Res (2008) 0.83
TSPAN33 is a novel marker of activated and malignant B cells. Clin Immunol (2013) 0.82
Myosin 1g regulates cytoskeleton plasticity, cell migration, exocytosis, and endocytosis in B lymphocytes. Eur J Immunol (2014) 0.81
DNA priming E and NS1 constructs--homologous proteins boosting immunization strategy to improve immune response against dengue in mice. Viral Immunol (2005) 0.81
The spreading of B lymphocytes induced by CD44 cross-linking requires actin, tubulin, and vimentin rearrangements. J Leukoc Biol (2003) 0.81
Innate defects of the IL-12/IFN-γ axis in susceptibility to infections by mycobacteria and salmonella. J Interferon Cytokine Res (2013) 0.81
Localization of CD38 in murine B lymphocytes to plasma but not intracellular membranes. Mol Immunol (2005) 0.81
A potential role for plasma uric acid in the endothelial pathology of Plasmodium falciparum malaria. PLoS One (2013) 0.80
Flagella from five Cronobacter species induce pro-inflammatory cytokines in macrophage derivatives from human monocytes. PLoS One (2012) 0.80
A plasmid encoding parts of the dengue virus E and NS1 proteins induces an immune response in a mouse model. Arch Virol (2010) 0.80
Production of IL-10, TNF and IL-12 by peripheral blood mononuclear cells in Mexican workers exposed to a mixture of benzene-toluene-xylene. Arch Med Res (2012) 0.80
Autoimmune thrombocytopenic purpura in partial DiGeorge syndrome: case presentation. J Pediatr Hematol Oncol (2011) 0.79
The CD19/CD81 complex physically interacts with CD38 but is not required to induce proliferation in mouse B lymphocytes. Immunology (2012) 0.78
Mycobacterium tuberculosis Beijing genotype induces differential cytokine production by peripheral blood mononuclear cells of healthy BCG vaccinated individuals. Immunol Invest (2011) 0.78
Mycobacterial di-O-acyl trehalose inhibits Th-1 cytokine gene expression in murine cells by down-modulation of MAPK signaling. Immunobiology (2009) 0.78
Activated umbilical cord blood cells from pre-term and term neonates express CD69 and synthesize IL-2 but are unable to produce IFN-gamma. Arch Med Res (2003) 0.78
Mycobacterium tuberculosis H37Rv induces ectosome release in human polymorphonuclear neutrophils. Tuberculosis (Edinb) (2010) 0.78
Tumor necrosis factor receptor 2 M196R polymorphism in rheumatoid arthritis and osteoarthritis: relationship with sTNFR2 levels and clinical features. Rheumatol Int (2006) 0.77
DENV-2 subunit proteins fused to CR2 receptor-binding domain (P28)-induces specific and neutralizing antibodies to the Dengue virus in mice. Hum Vaccin Immunother (2013) 0.77
Granulocyte colony-stimulating factor produces a decrease in IFNgamma and increase in IL-4 when administrated to healthy donors. J Clin Apher (2010) 0.77
O-glycosylation of NnTreg lymphocytes recognized by the Amaranthus leucocarpus lectin. Clin Dev Immunol (2013) 0.77
Consequences of two naturally occurring missense mutations in the structure and function of Bruton agammaglobulinemia tyrosine kinase. IUBMB Life (2012) 0.76
Dialyzable leukocyte extracts activate TLR-2 on monocytes. Nat Prod Commun (2014) 0.76
Epidermal keratinocytes do not activate peripheral T-cells: interleukin-10 as a possible regulator. Immunology (2008) 0.76
Expression of Mycobacterium leprae HSP65 in tobacco and its effectiveness as an oral treatment in adjuvant-induced arthritis. Transgenic Res (2010) 0.76
Differential activation of dendritic cells by Mycobacterium tuberculosis Beijing genotype. Immunol Invest (2014) 0.76
Evidence that thalidomide modifies the immune response of patients suffering from actinic prurigo. Int J Dermatol (2004) 0.75
CD38 expression in early B-cell precursors contributes to extracellular signal-regulated kinase-mediated apoptosis. Immunology (2015) 0.75
NIM-R7, a novel marker for resting B1 and marginal-zone B lymphocytes, is also expressed on activated T and B cells. Immunology (2003) 0.75
Dengue virus replicative intermediate RNA detection by reverse transcription-PCR. Clin Diagn Lab Immunol (2002) 0.75
Severe combined immunodeficiency syndrome associated with colonic stenosis. Arch Med Res (2004) 0.75
Immunogenicity of a 23-valent pneumococcal polysaccharide vaccine among Mexican children. Arch Med Res (2012) 0.75
[Disseminated Tuberculosis in an Infant with IFNg-IL-12/IL 23 Axis Defect]. Rev Alerg Mex (2013) 0.75
Differential localization of unconventional myosin I and nonmuscle myosin II during B cell spreading. Exp Cell Res (2006) 0.75
[Hematopoietic progenitors transplantation in a patient with chronic granulomatous disease in Mexico]. Rev Alerg Mex (2016) 0.75
[Malignancies in adult patients with common variable immunodeficiency]. Rev Alerg Mex (2015) 0.75
[Wiskott-Aldrich Syndrome: An updated review]. Rev Alerg Mex (2013) 0.75
[Basics of primary immunodeficiencies]. Rev Alerg Mex (2016) 0.75
Identification of Helicobacter pylori strain cagPAI+ and cagPAI- Antigens by IgG antibodies from sera of experimentally colonized meriones unguiculatus (Mongolian gerbils). Helicobacter (2011) 0.75
[Infection due to Mycobacterium bovis in common variable immunodeficiency]. Rev Alerg Mex (2015) 0.75
Medium-sized arterial vasculitis associated with vascular deposits of immunoglobin E. Favorable response to intravenous methylprednisolone and cyclophosphamide. Arch Med Res (2002) 0.75
Activation and proliferation of T lymphocyte subpopulations in patients with brucellosis. Arch Med Res (2003) 0.75
[Chronic granulomatous disease]. Rev Alerg Mex (2009) 0.75
[Refractory, incomplete and atypical Kawasaki disease. Case report and review of the literature]. Arch Cardiol Mex (2011) 0.75
Preparation and characterization of a monoclonal antibody specific to Plasmodium falciparum TATA binding protein. Hybridoma (Larchmt) (2006) 0.75
Preparation and characterization of a monoclonal antibody specific to histone acetyltransferase from Plasmodium falciparum. Hybridoma (Larchmt) (2005) 0.75
[Clinical and therapeutic features in patients with common variable immunodeficiency from two third-level care hospitals from Mexico City]. Rev Alerg Mex (2013) 0.75
Measurement of suppressor activity of T CD4⁺CD25⁺ T reg cells using bromodeoxyuridine incorporation assay. Immunol Invest (2013) 0.75
Integrated measurements by flow cytometry of the cytokines IL-2, IFN-gamma, IL-12, TNF-alpha and functional evaluation of their receptors in human blood. J Immunol Methods (2003) 0.75
Pediatric Churg-Strauss syndrome in Mexico. Pediatr Pulmonol (2006) 0.75
Generation and characterization of a monoclonal antibody that cross-reacts with the envelope protein from the four dengue virus serotypes. APMIS (2013) 0.75
[Kawasaki Disease and Henoch-Schönlein Purpura: Frequent Vasculitis in an Infrequent Association]. Rev Alerg Mex (2013) 0.75
[Hematopoietic stem cells transplant in patients with common variable immunodeficiency. Is a therapeutic option?] Rev Alerg Mex (2017) 0.75
Successful adjunctive immunoglobulin treatment in patients affected by leukocyte adhesion deficiency type 1 (LAD-1). Immunol Res (2015) 0.75
[Is the Down syndrome a primary immunodeficiency?]. Rev Alerg Mex (2013) 0.75
[Innate lymphoid cells and their role in immune response regulation]. Rev Alerg Mex (2017) 0.75
Characterization of langerhans cells in epidermal sheets along the body of Armadillo (Dasypus novemcinctus). Vet Immunol Immunopathol (2008) 0.75
A novel CD40LG deletion causes the hyper-IgM syndrome with normal CD40L expression in a 6-month-old child. Immunol Res (2015) 0.75